The vessels encapsulating tumor clusters (VETC) pattern is a negative predictor for first-line immune checkpoint inhibitors alone in unresectable hepatocellular carcinoma
Journal of Gastroenterology · 2026-08 · 61 (8) · 1135-1145
DOI: 10.1007/s00535-026-02421-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology, online erschienen am 24.04.2026. Verfasst von Chunyu Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Tumor Center, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Immune Checkpoint Inhibitors. Die Arbeit nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Vessels encapsulating tumor clusters (VETC), an aggressive pathological pattern in hepatocellular carcinoma (HCC), is associated with unfavorable clinical outcomes. However, its role in first-line systemic therapies-immune checkpoint inhibitors alone (ICI-alone), tyrosine kinase inhibitors (TKIs) alone, or ICIs-based combinations (ICI-combo)-remains largely unexplored. This study aimed to compare therapy efficacy in unresectable HCC (uHCC) stratified by VETC. METHODS: A retrospective analysis of 111 uHCC patients (ICI-alone, n = 34; TKIs, n = 24; ICI-combo, n = 53) used pooled data from 19 prospective studies (2017-2024). Objective response rate (ORR), investigator-assessed progression-free survival (PFS), overall survival (OS), and pathological characteristics were investigated. Tumor immune microenvironment was compared between the VETC and non-VETC by immunohistochemistry and transcriptome sequencing. RESULTS: With a median follow-up of 47.9 months, ICI-combo cohort demonstrated significantly superior ORR (49.1% vs. 20.6% [ICI-alone] vs. 16.7% [TKIs], P = 0.003) and mPFS (8.57 vs. 2.10 vs. 3.97 months, P = 0.005), though no significant difference in OS was observed (median, 19.27 vs. 12.87 vs. 13.90 months, P = 0.070). VETC-positive patients receiving ICI-alone had markedly inferior outcomes (DCR, 9.1%; mPFS, 1.63 months; mOS, 3.47 months) compared to those receiving TKIs or ICI-combo (P < 0.05). Multivariate analysis confirmed VETC as an independent negative OS predictor in the ICI-alone cohort (HR = 3.42, P = 0.013). VETC tumors exhibited an immunosuppressive microenvironment (reduced CD8+ T/CD20+ B-cell infiltration and M2-like macrophage dominance), corroborated by transcriptomic downregulation of T/B cells and M1 macrophage-related genes. CONCLUSIONS: VETC, characterized by reduced immune infiltration, is a negative predictor of first-line ICIs alone in uHCC, guiding personalized treatment selection in uHCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Liver Tumor Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Department of Radiology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Department of Digestive Tumors Multidisciplinary Treatment, Digestive Medicine Center, Guangdong Provincial Key Laboratory of Digestive Cancer Research, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen,…
- Department of Pathology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
- Department of Liver Tumor Center, Nanfang Hospital, Southern Medical University, Guangzhou, China. liufang@sysush.com.
ORCID-Profile: Fang Liu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Lin, C., Kang, S., Zhang, J., Yu, W., Wang, X., Huang, X., Cao, Q., & Liu, F. (2026). The vessels encapsulating tumor clusters (VETC) pattern is a negative predictor for first-line immune checkpoint inhibitors alone in unresectable hepatocellular carcinoma. Journal of Gastroenterology, 61(8), 1135-1145. https://doi.org/10.1007/s00535-026-02421-5
Vancouver
Lin C, Kang S, Zhang J, Yu W, Wang X, Huang X, et al. The vessels encapsulating tumor clusters (VETC) pattern is a negative predictor for first-line immune checkpoint inhibitors alone in unresectable hepatocellular carcinoma. Journal of Gastroenterology. 2026;61(8):1135-1145. doi:10.1007/s00535-026-02421-5
BibTeX
@article{Lin2026,
author = {Lin, Chunyu and Kang, Shuai and Zhang, Jing and Yu, Wenxuan and Wang, Xiaoqun and Huang, Xiangqi and Cao, Qinghua and Liu, Fang},
title = {The vessels encapsulating tumor clusters (VETC) pattern is a negative predictor for first-line immune checkpoint inhibitors alone in unresectable hepatocellular carcinoma},
journal = {Journal of Gastroenterology},
year = {2026},
volume = {61},
number = {8},
pages = {1135--1145},
doi = {10.1007/s00535-026-02421-5}
}
EUVIMED